The ratings agency has affirmed BBB ratings for Thermo Fisher's long term issuer default rating, senior notes, and bank revolving credit facility.
The ratings firm noted Thermo Fisher's efforts to bring down its debt and said that the company could resume bolt-on acquisitions next year.
The story has been updated with information about the pricing of the notes released by Agilent after the close of the market.
NEW YORK (GenomeWeb News) – Standard & Poor's on Thursday raised Life Technologies' corporate credit rating and the issue-level rating on the firm's secured and unsecured debt to BBB+.
By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Fitch Ratings late on Tuesday affirmed several ratings of BBB+ for Agilent Technologies.
Morningstar said that the rating reflects its negative view of the genetic analysis instrument business and potential competitive pressure for Illumina.
The rating agency raised its outlook on Agilent to 'positive' from 'stable' due to "greater confidence in Agilent's operating and financial profile."
S&P cited Bio-Rad's "solid operating performance and cash flow generation" in announcing the upgrade.
New results from the NASA Twins Study indicate that the immune system may rev up when in space, the Washington Post reports.
Kelvin Droegemeier, the new science advisor, spoke at the American Association for the Advancement of Science meeting, Geekwire reports.
In PNAS this week: whole-genome assembly for the white shark, paper-based microfluidic method for detecting the malaria parasite, and more.
The World Health Organization has announced the members of its gene-editing committee, according to NPR.